drugset / Trial / NCT01288807

Effect of Milnacipran on Pain in Fibromyalgia

NCT01288807

NaSingle-groupOpen-labelTreatment

Summary

The investigators want to study the effects of milnacipran treatment on neurotransmitter release in fibromyalgia.

Timeline

Start
2011-02
Primary completion
2015-01
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Milnacipran Other / unclassified 200 mg Oral

Indications